| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis.
|
Lancet
|
2005
|
7.09
|
|
2
|
Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial.
|
Lancet
|
2007
|
5.81
|
|
3
|
Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus.
|
Oncogene
|
2006
|
2.56
|
|
4
|
Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study.
|
Br J Cancer
|
2004
|
2.33
|
|
5
|
Penile cancer: epidemiology, pathogenesis and prevention.
|
World J Urol
|
2008
|
2.14
|
|
6
|
Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix.
|
J Pathol
|
2006
|
2.02
|
|
7
|
Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study.
|
Br J Cancer
|
2006
|
1.83
|
|
8
|
Prevalence and determinants of human papillomavirus genital infection in men.
|
Br J Cancer
|
2002
|
1.83
|
|
9
|
Papillomavirus infection in rural women in southern India.
|
Br J Cancer
|
2005
|
1.79
|
|
10
|
Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials.
|
Ann Oncol
|
2013
|
1.77
|
|
11
|
Human papillomavirus infection in Shenyang City, People's Republic of China: A population-based study.
|
Br J Cancer
|
2006
|
1.62
|
|
12
|
HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications.
|
Br J Cancer
|
2012
|
1.53
|
|
13
|
HPV infection in women with and without cervical cancer in Conakry, Guinea.
|
Br J Cancer
|
2009
|
1.50
|
|
14
|
Clinical validation of the cobas 4800 HPV test for cervical screening purposes.
|
J Clin Microbiol
|
2011
|
1.47
|
|
15
|
Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands.
|
Br J Cancer
|
2006
|
1.43
|
|
16
|
Validation of high-risk HPV tests for primary cervical screening.
|
J Clin Virol
|
2009
|
1.35
|
|
17
|
Prevalence and determinants of human papillomavirus infection and cervical lesions in HIV-positive women in Kenya.
|
Br J Cancer
|
2012
|
1.34
|
|
18
|
[Flat penile lesions in the sexual transmission of human papillomavirus].
|
Ned Tijdschr Geneeskd
|
2008
|
1.32
|
|
19
|
Sequential gene promoter methylation during HPV-induced cervical carcinogenesis.
|
Br J Cancer
|
2007
|
1.32
|
|
20
|
A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions.
|
J Clin Pathol
|
2005
|
1.31
|
|
21
|
Cervical cancer screening: on the way to a shift from cytology to full molecular screening.
|
Ann Oncol
|
2014
|
1.30
|
|
22
|
Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC.
|
J Pathol
|
2008
|
1.28
|
|
23
|
Cross-sectional comparison of an automated hybrid capture 2 assay and the consensus GP5+/6+ PCR method in a population-based cervical screening program.
|
J Clin Microbiol
|
2006
|
1.24
|
|
24
|
High-risk HPV type-specific clearance rates in cervical screening.
|
Br J Cancer
|
2007
|
1.24
|
|
25
|
Comparison of three different PCR methods for quantifying human papillomavirus type 16 DNA in cervical scrape specimens.
|
J Clin Microbiol
|
2005
|
1.20
|
|
26
|
Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland.
|
Eur J Cancer
|
2008
|
1.17
|
|
27
|
Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening.
|
Br J Cancer
|
2008
|
1.16
|
|
28
|
Expression of the p16(INK4a) gene product, methylation of the p16(INK4a) promoter region and expression of the polycomb-group gene BMI-1 in squamous cell lung carcinoma and premalignant endobronchial lesions.
|
Lung Cancer
|
2005
|
1.13
|
|
29
|
Long-term protective effect of high-risk human papillomavirus testing in population-based cervical screening.
|
Br J Cancer
|
2005
|
1.12
|
|
30
|
HPV testing and monitoring of women after treatment of CIN 3: review of the literature and meta-analysis.
|
Obstet Gynecol Surv
|
2004
|
1.10
|
|
31
|
Human papillomavirus infection in women with and without cervical cancer in Karachi, Pakistan.
|
Br J Cancer
|
2010
|
1.10
|
|
32
|
Clinical relevance of human papillomavirus testing in cytopathology.
|
Cytopathology
|
2005
|
1.08
|
|
33
|
Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis.
|
Oncogene
|
2012
|
1.06
|
|
34
|
A panel of high resolution melting (HRM) technology-based assays with direct sequencing possibility for effective mutation screening of EGFR and K-ras genes.
|
Cell Oncol
|
2009
|
1.05
|
|
35
|
TP53 mutation and human papilloma virus status of oral squamous cell carcinomas in young adult patients.
|
Oral Dis
|
2013
|
1.02
|
|
36
|
MAL promoter hypermethylation as a novel prognostic marker in gastric cancer.
|
Br J Cancer
|
2008
|
1.00
|
|
37
|
A fast, sensitive and accurate high resolution melting (HRM) technology-based assay to screen for common K-ras mutations.
|
Cell Oncol
|
2009
|
0.97
|
|
38
|
Specific p53 immunostaining patterns are associated with smoking habits in patients with oral squamous cell carcinomas.
|
J Clin Pathol
|
2002
|
0.97
|
|
39
|
High-throughput genotyping of high-risk HPV by the digene HPV Genotyping LQ Test using GP5+/6+-PCR and xMAP technology.
|
J Clin Virol
|
2009
|
0.97
|
|
40
|
Prevalence of genital HPV infections and HPV serology in adolescent girls, prior to vaccination.
|
Cancer Epidemiol
|
2012
|
0.96
|
|
41
|
Comparison of GP5+/6+-PCR and SPF10-line blot assays for detection of high-risk human papillomavirus in samples from women with normal cytology results who develop grade 3 cervical intraepithelial neoplasia.
|
J Clin Microbiol
|
2008
|
0.96
|
|
42
|
HPV type concordance in sexual couples determines the effect of condoms on regression of flat penile lesions.
|
Br J Cancer
|
2005
|
0.94
|
|
43
|
Promoter methylation analysis of WNT/β-catenin signaling pathway regulators to detect adenocarcinoma or its precursor lesion of the cervix.
|
Gynecol Oncol
|
2011
|
0.93
|
|
44
|
Suprabasal p53 immunoexpression is strongly associated with high grade dysplasia and risk for malignant transformation in potentially malignant oral lesions from Northern Ireland.
|
J Clin Pathol
|
2002
|
0.93
|
|
45
|
Comparison of the clinical performance of PapilloCheck human papillomavirus detection with that of the GP5+/6+-PCR-enzyme immunoassay in population-based cervical screening.
|
J Clin Microbiol
|
2009
|
0.92
|
|
46
|
Role of paan chewing and dietary habits in cervical carcinoma in Chennai, India.
|
Br J Cancer
|
2003
|
0.89
|
|
47
|
Effects of HPV detection in population-based screening programmes for cervical cancer; a Dutch moment.
|
Gynecol Oncol
|
2005
|
0.89
|
|
48
|
The contribution of HPV18 to cervical cancer is underestimated using high-grade CIN as a measure of screening efficiency.
|
Br J Cancer
|
2007
|
0.88
|
|
49
|
Clinical validation of the Abbott RealTime High Risk HPV assay according to the guidelines for human papillomavirus DNA test requirements for cervical screening.
|
J Clin Microbiol
|
2013
|
0.87
|
|
50
|
The Aptima HPV assay fulfills the cross-sectional clinical and reproducibility criteria of international guidelines for human papillomavirus test requirements for cervical screening.
|
J Clin Microbiol
|
2013
|
0.85
|
|
51
|
High genotyping concordance between the digene HPV Genotyping RH Test and the Reverse Line Blot genotyping assay on GP5+/6+-PCR products.
|
J Clin Virol
|
2009
|
0.83
|
|
52
|
Long-term CIN3+ risk in women with abnormal cytology; role of hrHPV testing.
|
Br J Cancer
|
2012
|
0.81
|
|
53
|
Methylation marker analysis of self-sampled cervico-vaginal lavage specimens to triage high-risk HPV-positive women for colposcopy.
|
Int J Cancer
|
2014
|
0.81
|
|
54
|
High-risk human papillomavirus (hrHPV) E6/E7 mRNA testing by PreTect HPV-Proofer for detection of cervical high-grade intraepithelial neoplasia and cancer among hrHPV DNA-positive women with normal cytology.
|
J Clin Microbiol
|
2012
|
0.80
|
|
55
|
Human papillomavirus and cervical cancer from a prospective study in Khon Kaen, Northeast Thailand.
|
Int J Gynecol Cancer
|
2006
|
0.78
|
|
56
|
High-risk human papillomavirus is present in cytologically false-negative smears: an analysis of "normal" smears preceding CIN2/3.
|
J Clin Pathol
|
2007
|
0.78
|
|
57
|
Implementation of human papillomavirus testing in cervical screening without a concomitant decrease in participation rate.
|
J Clin Pathol
|
2006
|
0.78
|
|
58
|
Vaccination against HPV: indications for women and the impact on the cervical screening programme.
|
BJOG
|
2008
|
0.78
|
|
59
|
Agreement between colposcopic impression and histological diagnosis among human papillomavirus type 16-positive women: a clinical trial using dynamic spectral imaging colposcopy.
|
BJOG
|
2012
|
0.78
|
|
60
|
Detection of human papillomavirus DNA in primary squamous cell carcinoma and metastases.
|
Br J Dermatol
|
2006
|
0.77
|
|
61
|
Corrections.
|
Lancet Infect Dis
|
2015
|
0.75
|
|
62
|
HrHPV-testing in a university hospital gynecology outpatient clinic: recommendations for clinical practice.
|
Gynecol Oncol
|
2011
|
0.75
|